Signal epitopes in the three-dimensional structure of neuropeptide Y. Interaction with Y1, Y2, and pancreatic polypeptide receptors. 1990

T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
University Department of Clinical Chemistry, Rigshospitalet, Copenhagen, Denmark.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D010191 Pancreatic Polypeptide A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice. Pancreatic Polypeptide (PP),Pancreatic Polypeptide Hormone,Pancreatic Prohormone
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D003461 Crystallography The branch of science that deals with the geometric description of crystals and their internal arrangement. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystallographies
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
March 1993, European journal of pharmacology,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
March 1989, FEBS letters,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
May 2002, Peptides,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
January 1995, Biopolymers,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
December 1996, European journal of pharmacology,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
January 1990, Annals of the New York Academy of Sciences,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
February 2003, Peptides,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
October 2015, General and comparative endocrinology,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
September 1998, Regulatory peptides,
T W Schwartz, and J Fuhlendorff, and L L Kjems, and M S Kristensen, and M Vervelde, and M O'Hare, and J L Krstenansky, and B Bjørnholm
March 2002, British journal of pharmacology,
Copied contents to your clipboard!